Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JACLYN FLICKINGER

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1003158494
CMS profile
3677909
Location
TALLMADGE, OH

General Payments · PY2018–2024

$1,531.16

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$263.05

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $263.05 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Exeltis, USA Inc. $66.21 4
Agile Therapeutics, Inc. $44.87 2
Astellas Pharma US Inc $38.14 2
Organon LLC $38.07 2
ABBVIE INC. $25.56 1
PFIZER INC. $18.49 1
Sumitomo Pharma America, Inc. $17.32 1
CooperSurgical, Inc. $14.39 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $300.96 15
PY2019 $506.49 25
PY2020 $175.14 11
PY2022 $26.13 1
PY2023 $259.39 13
PY2024 $263.05 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.56 10/25/2024 Food and Beverage Undisputed 01/23/2026 1103736831 CMS
Agile Therapeutics, Inc. $22.50 04/12/2024 Food and Beverage Undisputed 01/23/2026 1154844283 CMS
Agile Therapeutics, Inc. $22.37 04/30/2024 Food and Beverage Undisputed 01/23/2026 1154841891 CMS
Astellas Pharma US Inc $19.14 01/31/2024 Food and Beverage Undisputed 01/23/2026 1139293086 CMS
Astellas Pharma US Inc $19.00 04/15/2024 Food and Beverage Undisputed 01/23/2026 1139321074 CMS
CooperSurgical, Inc. $14.39 10/23/2024 Food and Beverage Undisputed 01/23/2026 1150790079 CMS
Exeltis, USA Inc. $16.34 03/18/2024 Food and Beverage Undisputed 01/23/2026 1149993071 CMS
Exeltis, USA Inc. $16.26 08/26/2024 Food and Beverage Undisputed 01/23/2026 1149993073 CMS
Exeltis, USA Inc. $15.49 11/18/2024 Food and Beverage Undisputed 01/23/2026 1149993075 CMS
Exeltis, USA Inc. $18.12 12/09/2024 Food and Beverage Undisputed 01/23/2026 1149993077 CMS
Organon Llc $19.07 04/17/2024 Food and Beverage Undisputed 01/23/2026 1136283490 CMS
Organon Llc $19.00 12/17/2024 Food and Beverage Undisputed 01/23/2026 1136283486 CMS
PFIZER INC. $18.49 09/17/2024 Food and Beverage Undisputed 01/23/2026 1131396116 CMS
Sumitomo Pharma America, Inc. $17.32 10/22/2024 Food and Beverage Undisputed 01/23/2026 1148851617 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.